Eupraxia Pharmaceuticals EPRX Q1 2026 Earnings Clinical Progress Overshadows Slight EPS Miss QCLS Q4 2017 Earnings Massive EPS Miss Reflects Operational Challenges BEEM Q1 2026 Earnings EPS Misses Estimates as Beam Global Reports WiderThanExpected Loss Vision Marine Technologies VMAR Q4 2025 Earnings Massive EPS Surprise Overshadowed by 10 Stock Decline LGCY Q1 2026 Earnings EPS Beats Estimates by 244 Revenue Not Disclosed Legato Merger Corp III LEGT Q1 2026 Earnings Positive EPS Reported Amid PreMerger Quiet Period